Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making.
- DOI
- 10.1007/s13730-026-01200-8
- Published
- 2026 Oct 27
- Container
- CEN case reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13730-026-01200-8,
title = {Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making.},
author = {Yoshii R and Kajiwara K and Hirose K and Hatanaka T and Shimasaki A and Tomita M and Yokoi H},
year = {2026},
journal = {CEN case reports},
doi = {10.1007/s13730-026-01200-8},
url = {https://doi.org/10.1007/s13730-026-01200-8}
}RIS
TY - JOUR TI - Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making. AU - Yoshii R AU - Kajiwara K AU - Hirose K AU - Hatanaka T AU - Shimasaki A AU - Tomita M AU - Yokoi H PY - 2026 JO - CEN case reports DO - 10.1007/s13730-026-01200-8 UR - https://doi.org/10.1007/s13730-026-01200-8 ER -
APA
R, Y., K, K., K, H., T, H., A, S., M, T., & H, Y. (2026). Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making.. CEN case reports. https://doi.org/10.1007/s13730-026-01200-8
Source records
- pubmed · retrieved 2026-11-10T20:39:02.635Z